Nvidia will report fiscal 2025 Q4 results after market close on February 25, 2026, and Wall Street expects another strong quarter. Consensus estimates call for about $65.6 billion in revenue and $1.52 adjusted earnings per share, each near 71% year-over-year growth.
Analysts warn the stock could fall even on a beat because traders track higher “whisper numbers” and markets often price in strong results ahead of earnings. If management flags HBM memory constraints that could curb GPU sales later in 2026, investors might react negatively (Ed. note: the stock fell after three of the last four quarterly beats).
Skepticism about AI infrastructure spending also pressures sentiment after recent sell-offs at Microsoft, Alphabet, and warnings tied to Amazon capital expenditure forecasts, all big Nvidia customers. Some investors fear the same capex scrutiny could spill over to Nvidia.
Analyst coverage remains overwhelmingly positive, with 57 Buys, three Holds, and one Sell among 61 ratings. The average 12-month price target sits near $253.88, implying roughly 35% upside, with a high of $352 and a low of $140.
Recent firm targets include $250 from Stifel and Goldman Sachs, $275 from Jefferies and Baird, $270 from Citi, and $245 from UBS after its February 11, 2026 update.
Bank of America analyst Vivek Arya and his team raised their AI data-center TAM to about $1.4 trillion by 2030, up from $1.2 trillion, and now model roughly $748 billion in cloud capex for 2026. Their work also cites about a $120 billion increase in potential compute chip sales, aligning with a roughly $110 billion rise in data-center compute demand, as reported.
Long-term bulls point to a Rubin architecture ramp later in 2026 and dominant share in accelerators, cited at about 80%–90% revenue. Trevor Jennewine noted estimates for 38% annual earnings growth, and wrote that “the current valuation of 45 times earnings look[s] relatively cheap”.
Whether the share price dips immediately after the report, the consensus view remains bullish on Nvidia over the medium and long term.
